𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In Vitro Response to HBsAg of Peripheral Blood Lymphocytes from Recipients of Hepatitis B Vaccine

✍ Scribed by Tse Wen Chang; Esteban Celis; Richard W. Miller; Vincent R. Zurawski Jr.; Patrick C. Kung


Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
712 KB
Volume
4
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


Lymphocytes isolated from recipients of hepatitis B vaccine were studied for their immune response to HBsAg in uitro. Peripheral blood mononuclear cells (PBMs) from 70 to 80% of 40 vaccinees yielded proliferative indices larger than 2 after 5 to 7 days incubation with HBsAg. This in uitro proliferative response could be augmented by incubating the cells with HBsAg and supernatants of activated T cells for 2 weeks or longer. After 7 to 10 days, in vitro stimulation with antigen, PBMs (1 x lo8) could yield 5 to 15 HBsAg-specific antibody-secreting plaqueforming cells. The antibody to HBsAg produced in vitro was greatly increased in cultures that contained antigen-specific B cells enriched by panning with HBsAg-coated plates and a T cell growth factor-dependent, HBsAg-specific autologous T cell line. The results indicate that HBsAgspecific B and T cells are present, although at low frequencies, in the circulation of hepatitis B vaccinees.

Hepatitis B still remains the most serious infectious liver disease (1, 2). Contributing to this problem is that some individuals fail to mount an effective immune response to hepatitis B virus (HBV) infection and become chronic carriers of the virus (3). It is important to study how the various components of the immune system of normal individuals and HBV-bearing patients respond to the virus and its components. Such studies will help in understanding the pathology of hepatitis B and improving prevention methods.

The induction of most immune responses are known to involve complicated interactions between immunocyte subsets and regulatory factors. In recent years, the studies on the regulation of immune responses have been advanced greatly by analyzing responses of immunocytes under defined conditions in uitro (e.g., 4-6). Of interest is to examine in the in uitro systems whether the variation in the ability of individuals to respond to HBV infection lies in differences in certain regulatory mechanisms. The studies of Chisari et al. (7, 8), Alexander et al. (9) and Mondelli et al. (10) on the analysis of the involvement of cytotoxic and suppressor T cells in hepatitis B are excellent examples of these in uitro studies.

Because the production of antibodies against HBsAg plays a major role in the immune response against HBV ~


πŸ“œ SIMILAR VOLUMES


Response to hepatitis B vaccine in famil
✍ Anna Suk-Fong Lok; Matthew Mai-Tai Ng; Ching-Lung Lal; Pul-Chee Wu πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 410 KB πŸ‘ 1 views

The family members of HBsAg camers have an increased risk of hepatitis B virus (HBV) infection. 214 subjects from 98 families with no HBV markers were randomized to receive hepatitis B vaccine: HEVAC B (Institute Pasteur) or GCC VAC (Green Cross Corporation) at 0, 1, and 5 months. Of those who compl

Vaccination against hepatitis B in liver
✍ Tanja Bauer; Matthias GΓΌnther; Ulrich Bienzle; Ruth Neuhaus; Wolfgang Jilg πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 214 KB πŸ‘ 1 views

After liver transplantation for hepatitis-B-related diseases, patients currently receive lifelong treatment with hepatitis B immunoglobulin to prevent endogenous reinfection with hepatitis B virus (HBV). Active immunization with hepatitis B vaccine would be a preferable alternative; however, most at

Depressed in vitro peripheral blood lymp
✍ Marek Zembala; Bozena Mytar; Tadeusz Popiela; Geoffrey L. Asherson πŸ“‚ Article πŸ“… 1977 πŸ› John Wiley and Sons 🌐 French βš– 783 KB

## Abstract The reactivity of peripheral blood lymphocytes from patients with advanced malignancy was assessed by mitogen‐induced stimulation of protein synthesis as measured by ^3^H‐leucine incorporation. It was confirmed that the lymphocyte response of patients was depressed. Furthermore, the lym

In vitro detection of Mycoplasma ferment
✍ Robert F. Cheek; Iwona Olszak; Sarabelle Madoff; Frederic I. Preffer πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 130 KB πŸ‘ 2 views

Previous reports have shown, using fluorescent probes conjugated to the organism, that Mycoplasma fermentans fuses with about 12% of peripheral blood lymphocytes. However, no lymphocyte subset was specified. To elucidate the specific subset of lymphocytes involved, we developed a threecolor flow cyt